Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants.
N Engl J Med
; 386(9): 837-846, 2022 03 03.
Article
in En
| MEDLINE
| ID: mdl-35235726
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Infant, Premature
/
Respiratory Syncytial Virus Infections
/
Antibodies, Monoclonal, Humanized
/
Infant, Premature, Diseases
Type of study:
Clinical_trials
Limits:
Female
/
Humans
/
Infant
/
Male
/
Newborn
Language:
En
Journal:
N Engl J Med
Year:
2022
Type:
Article